Insider Transactions in Q4 2023 at Pulse Biosciences, Inc. (PLSE)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
17,999
+0.05%
|
$161,991
$9.15 P/Share
|
|
Dec 11
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
90,118
+0.24%
|
$811,062
$9.36 P/Share
|
|
Dec 08
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
116,656
+0.32%
|
$1,049,904
$9.54 P/Share
|
|
Dec 07
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
74,852
+0.2%
|
$673,668
$9.19 P/Share
|
|
Dec 06
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
82,813
+0.23%
|
$745,317
$9.06 P/Share
|
|
Dec 06
2023
|
Robert W Duggan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,933
+0.03%
|
$49,665
$5.95 P/Share
|
|
Dec 05
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Indirect |
66,021
+15.81%
|
$594,189
$9.34 P/Share
|
|
Dec 04
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Indirect |
27,000
+8.64%
|
$270,000
$10.38 P/Share
|
|
Dec 04
2023
|
Robert W Duggan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,347
+0.06%
|
$403,470
$10.66 P/Share
|
|
Dec 01
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Indirect |
45,600
+14.99%
|
$410,400
$9.07 P/Share
|
|
Nov 30
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Indirect |
152,944
+41.8%
|
$1,376,496
$9.06 P/Share
|
|
Nov 29
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Indirect |
60,000
+50.0%
|
$540,000
$9.21 P/Share
|
|
Nov 29
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
158,600
+0.43%
|
$1,427,400
$9.44 P/Share
|
|
Nov 29
2023
|
Robert W Duggan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,667
+0.0%
|
$8,335
$5.95 P/Share
|
|
Nov 28
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
124,397
+0.34%
|
$995,176
$8.98 P/Share
|
|
Nov 17
2023
|
Robert W Duggan Director |
BUY
Open market or private purchase
|
Direct |
20,241
+0.02%
|
$121,446
$6.1 P/Share
|
|
Nov 16
2023
|
Kevin Patrick Danahy Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
5,393
+4.54%
|
$32,358
$6.51 P/Share
|
|
Nov 15
2023
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Open market or private purchase
|
Indirect |
13,539
+31.4%
|
$67,695
$5.93 P/Share
|
|
Nov 15
2023
|
Mitchell E. Levinson Chief Strategy Officer |
BUY
Open market or private purchase
|
Direct |
4,261
+2.8%
|
$21,305
$5.86 P/Share
|
|
Nov 13
2023
|
Maky Zanganeh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,075
+6.0%
|
$152,150
$2.14 P/Share
|
|
Nov 07
2023
|
Robert W Duggan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,265
+0.02%
|
$66,325
$5.95 P/Share
|